SetPFPGroupVar.htm
   
SetPProProdListVar.htm

New User? Register Now

Returning User? Sign In

Benefits of registering


login.htm

Visit other Pfizer sites
Search Medical Responses
View an extensive list of Pfizer sites
ppn-vr-sso-links.htm

Share Your Feedback
Product Centers
 
Our Oncology Portfolio
Aromasin

AROMASIN (exemestane tablets) is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy.

AROMASIN is indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.

View AROMASIN
View prescribing information

Sutent

SUTENT (sunitinib malate) is indicated for the treatment of advanced renal cell carcinoma (RCC) and for the treatment of gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.


View SUTENT
View prescribing information


Camptosar

CAMPTOSAR (irinotecan hydrochloride injection) is indicated as a component of first-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum. CAMPTOSAR is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.

View CAMPTOSAR
View prescribing information


Ellence

ELLENCE (epirubicin hydrochloride injection) is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.

View ELLENCE
View prescribing information

Clinical Library


Clinical Library

Review an extensive selection of downloadable reprints, slides, and guidelines. go

Clinical Trial Information

Clinical Trials Info
Visit our Clinical Trials section for a comprehensive database of Pfizer and non-Pfizer trials. go

FirstRESOURCE

First Resource

Learn how the First Resource program can benefit your patients. Go


Important Safety Information for Aromasin AROMASIN® (exemestane tablets)

Back to Top

Important Safety Information for Camptosar CAMPTOSAR® (irinotecan hydrochloride injection)

Back to Top

Important Safety Information for Ellence Ellence® (epirubicin hydrochloride injection)

Back to Top

Important Safety Information for SUTENT
Sutent (sunitinib malate)

Back to Top

Aromasin Safety Information